Highlights and Quick Summary
- Shares (Basic, Weighted) for the quarter ending June 30, 2023 was $55.9 Million (a 0.07% increase compared to previous quarter)
- Year-over-year quarterly Shares (Basic, Weighted) increased by 0.3%
- Annual Shares (Basic, Weighted) for 2022 was $55.7 Million (a 21.27% increase from previous year)
- Annual Shares (Basic, Weighted) for 2021 was $45.9 Million (a 190.79% increase from previous year)
- Annual Shares (Basic, Weighted) for 2020 was $15.8 Million (a -71.6% decrease from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shares (Basic, Weighted) of Design Therapeutics, Inc.
Most recent Shares (Basic, Weighted)of DSGN including historical data for past 10 years.Interactive Chart of Shares (Basic, Weighted) of Design Therapeutics, Inc.
Design Therapeutics, Inc. Shares (Basic, Weighted) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $55.95 | $55.91 | – | – | – |
| 2022 | $55.71 | $55.78 | $55.67 | $55.51 | $55.71 |
| 2021 | $45.94 | $55.16 | $55.08 | $17.63 | $45.94 |
| 2020 | $15.8 | $25.7 | $25.6 | $15.67 | $15.8 |
| 2019 | – | – | – | – | $55.62 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology